| Disease | Target Count | P-value |
|---|---|---|
| juvenile dermatomyositis | 1187 | 1.4e-08 |
| ovarian cancer | 8520 | 1.3e-07 |
| osteosarcoma | 7950 | 8.3e-06 |
| glioblastoma | 5792 | 1.9e-05 |
| tuberculosis and treatment for 6 months | 409 | 2.7e-05 |
| Pick disease | 1894 | 2.2e-04 |
| dermatomyositis | 966 | 7.4e-04 |
| malignant mesothelioma | 3232 | 1.1e-03 |
| ependymoma | 4679 | 1.2e-02 |
| progressive supranuclear palsy | 676 | 1.7e-02 |
| intraductal papillary-mucinous neoplasm (IPMN) | 3291 | 1.8e-02 |
| intraductal papillary-mucinous adenoma (IPMA) | 2955 | 2.8e-02 |
| oligodendroglioma | 2850 | 3.6e-02 |
| Disease | Target Count | Z-score | Confidence |
|---|---|---|---|
| Conduct disorder | 33 | 0.0 | 3.0 |
| Type 2 diabetes mellitus | 272 | 0.0 | 1.5 |
| ulcerative colitis | 1819 | 0.0 | 1.2 |
| Disease | Target Count | Z-score | Confidence |
|---|---|---|---|
| Costello Syndrome | 17 | 3.771 | 1.9 |
| Beckwith-Wiedemann syndrome | 44 | 3.201 | 1.6 |
| Disease | log2 FC | p |
|---|---|---|
| dermatomyositis | 1.100 | 7.4e-04 |
| ependymoma | 1.400 | 1.2e-02 |
| glioblastoma | -1.400 | 1.9e-05 |
| intraductal papillary-mucinous adenoma (... | 1.100 | 2.8e-02 |
| intraductal papillary-mucinous neoplasm ... | 1.200 | 1.8e-02 |
| juvenile dermatomyositis | 1.063 | 1.4e-08 |
| malignant mesothelioma | 1.100 | 1.1e-03 |
| oligodendroglioma | 1.100 | 3.6e-02 |
| osteosarcoma | 1.531 | 8.3e-06 |
| ovarian cancer | -1.800 | 1.3e-07 |
| Pick disease | -1.800 | 2.2e-04 |
| progressive supranuclear palsy | -1.500 | 1.7e-02 |
| tuberculosis and treatment for 6 months | 1.400 | 2.7e-05 |
| Species | Source | Disease |
|---|---|---|
| Inparanoid OMA EggNOG | ||
| Inparanoid OMA EggNOG | ||
| Inparanoid OMA | ||
| Inparanoid OMA | ||
| Inparanoid OMA EggNOG | ||
| Inparanoid OMA EggNOG | ||
| Inparanoid OMA | ||
| Inparanoid OMA EggNOG | ||
| Inparanoid OMA | ||
| Inparanoid OMA EggNOG | ||
| OMA EggNOG |
MVSKMIIENFEALKSWLSKTLEPICDADPSALAKYVLALVKKDKSEKELKALCIDQLDVFLQKETQIFVE 1 - 70 KLFDAVNTKSYLPPPEQPSSGSLKVEFFPHQEKDIKKEEITKEEEREKKFSRRLNHSPPQSSSRYRENRS 71 - 140 RDERKKDDRSRKRDYDRNPPRRDSYRDRYNRRRGRSRSYSRSRSRSWSKERLRERDRDRSRTRSRSRTRS 141 - 210 RERDLVKPKYDLDRTDPLENNYTPVSSVPSISSGHYPVPTLSSTITVIAPTHHGNNTTESWSEFHEDQVD 211 - 280 HNSYVRPPMPKKRCRDYDEKGFCMRGDMCPFDHGSDPVVVEDVNLPGMLPFPAQPPVVEGPPPPGLPPPP 281 - 350 PILTPPPVNLRPPVPPPGPLPPSLPPVTGPPPPLPPLQPSGMDAPPNSATSSVPTVVTTGIHHQPPPAPP 351 - 420 SLFTADTYDTDGYNPEAPSITNTSRPMYRHRVHAQRPNLIGLTSGDMDLPPREKPPNKSSMRIVVDSESR 421 - 490 KRTIGSGEPGVPTKKTWFDKPNFNRTNSPGFQKKVQFGNENTKLELRKVPPELNNISKLNEHFSRFGTLV 491 - 560 NLQVAYNGDPEGALIQFATYEEAKKAISSTEAVLNNRFIKVYWHREGSTQQLQTTSPKVMQPLVQQPILP 561 - 630 VVKQSVKERLGPVPSSTIEPAEAQSASSDLPQNVTKLSVKDRLGFVSKPSVSATEKVLSTSTGLTKTVYN 631 - 700 PAALKAAQKTLLVSTSAVDNNEAQKKKQEALKLQQDVRKRKQEILEKHIETQKMLISKLEKNKTMKSEDK 701 - 770 AEIMKTLEVLTKNITKLKDEVKAASPGRCLPKSIKTKTQMQKELLDTELDLYKKMQAGEEVTELRRKYTE 771 - 840 LQLEAAKRGILSSGRGRGIHSRGRGAVHGRGRGRGRGRGVPGHAVVDHRPRALEISAFTESDREDLLPHF 841 - 910 AQYGEIEDCQIDDSSLHAVITFKTRAEAEAAAVHGARFKGQDLKLAWNKPVTNISAVETEEVEPDEEEFQ 911 - 980 EESLVDDSLLQDDDEEEEDNESRSWRR 981 - 1007 //
